A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)

Summary

In this study, CART cells are targeted to GPC3 by intratumor injected that we hope by this means could improve the local CAR-T cell numbers, meanwhile reduce the potential side effects.

Timeline

Start

2017-04-01

Primary completion

2018-03-31

Completion

2018-03-31

Drugs

Indications